PRDS News and Press, Pardes Biosciences Inc. From 05/02/23

2023-05-02 09:58:49 ET Summary Pardes Biosciences is a busted biopharma that is exploring strategic alternatives and trades at a wide 30% discount to its net cash. The company recently received a buyout proposal from its major shareholder/SPAC sponsor. Pardes Biosciences is li...

2023-04-24 09:13:31 ET Getty Images Holdings ( GETY ) +59% proposes to acquire Getty Images for $10 per share. IN8bio ( INAB ) +38% Presents Positive, New INB-100 Data Showing Long-term Complete Remissions and Elevated Gamma-Delta T Cells in 100% of Evaluable Tre...

2023-04-21 17:08:53 ET Pardes Biosciences ( NASDAQ: PRDS ) rose 12% in after hours trading after the SPAC sponsor, who took the company public, offered to buy the biopharma firm. Foresite Capital, which has a 27% stake in Pardes  ( PRDS ), said its exploring a pot...

2023-04-04 13:10:13 ET Jefferies has downgraded Pardes Biosciences ( NASDAQ: PRDS ) to hold from buy after a COVID-19 drug failed in a phase 2 trial. The candidate, pomotrelvir, did not meat its main goal and did not show meaningful improvement compared to placebo in ...

2023-04-03 09:45:13 ET Pardes Biosciences ( NASDAQ: PRDS ) stock fell ~13% on Monday after the company said it started a review of strategic alternatives after its COVID drug failed a phase 2 trial and oral antiviral's clinical development suspended. The phase 2 tr...

Pomotrelvir did not meet the primary endpoint measured by proportion of participants below the limit of detection for infectious SARS-CoV-2 on day 3 of treatment with pomotrelvir vs. placebo Otherwise healthy, vaccinated adults without risk factors for progression to severe disease ...

Data from ongoing Phase 2 trial evaluating pomotrelvir (formerly known as PBI-0451) for the treatment of COVID-19 expected in the coming weeks Cash to fund operations for the next twelve months CARLSBAD, Calif., March 14, 2023 (GLOBE NEWSWIRE) -- Pardes Biosciences, In...

Gainers: Reata Pharmaceuticals ( RETA ) +175% . OncoSec Medical ( ONCS ) +94% . B&G Foods ( BGS ) +30% . Nerdy ( NRDY ) +29% . SCYNEXIS ( SCYX ) +29% . Blackboxstocks ( BLBX ) +29% . Red Robin Gourmet Burgers ( RRGB ...

CARLSBAD, Calif., Feb. 01, 2023 (GLOBE NEWSWIRE) -- Pardes Biosciences, Inc. (NASDAQ: PRDS), a clinical-stage biopharmaceutical company developing PBI-0451 as a potential stand-alone novel direct-acting, oral antiviral drug candidate for the treatment and prevention of COVID-19, announced that ma...

This week could bring some fluctuations to the stock market. Whether you’re investing in penny stocks or more expensive shares, several key factors will shape the year’s first quarter. Economic data releases, earnings announcements, and the highly anticipated January FOMC meeting ar...